Harvard Bioscience Inc (NASDAQ:HBIO)

3.06
Delayed Data
As of 3:59pm ET
 -0.05 / -1.61%
Today’s Change
1.98
Today|||52-Week Range
6.49
+10.47%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$124.6M

Company Description

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Contact Information

Harvard Bioscience, Inc.
84 October Hill Road
Holliston Massachusetts 01746-1371
P:(508) 893-8999
Investor Relations:

Employees

Shareholders

Other institutional52.73%
Individual stakeholders29.94%
Mutual fund holders18.06%

Top Executives

James W. GreenChairman, President & Chief Executive Officer
Jennifer CoteChief Financial Officer & Treasurer
Ryan WallaceVice President-Global Sales, Preclinical Systems
Jacques CoumansChief Marketing Officer
John J. FrySecretary & Chief Legal Counsel